“If we fail to give people with diabetes the long and healthylives we are capable of giving them, we will not be forgiven.”
Bill Clinton, US President, 1993-2001Keynote lecture at the ‘Global Changing Diabetes Leadership Forum’, New York, 2007
“
Natural Wellbeing Global
Our Vision
CuraLife is a nutritional supplement company that targets wellness and a healthier future for sufferers of chronic illness through natural, non-prescription remedies.
Our goal is to become a Category Champion in the mass market, consumer healthcare market for non-prescription, scientifically proven products.
Who Are We?
Trials and
usage show
efficacy and
quick results
Proven
A vision to
make the world
a better,
healthier place
Responsible
Increase
efficacy and
new products
in development
Innovative
Advisory board
with recognized
industry
professionals
Trusted
Exclusive rights
in major
markets with a
global
exclusive right
Global
R&D
Our advanced R&D facility, situated on London, combines knowledge of traditional ancient effective remedies together with modern research, extraction and development capabilities bringing best in class, safe and effective products.
Management Team
Rafi Elul
Chairman
Rafi is CEO of the strategic
consulting and ventures firm
ISHRA. He served two terms
in the national Parliament
and continues to advise the
offices of President and PM.
He is Chairman of the
national volunteer program
‘Ruach Tova’.
Ron Elul
Chief Executive Officer
Ron heads business
development activity with
successful track record
marketing and innovative
start-ups. He maintains
responsibility for project
design, development and
penetrating new markets
worldwide.
Ofer Yigdal
Chief Operating Officer
Ofer is responsible for key accounts,
service delivery and operational
efficiency. As an experienced
marketing professional, he has
worked with many of the major
health and wellness brands in Israel
and has experience of both channel
andproductmarketing.
CEO COOCHAIR VP
Henry Yahav
VP Sales & Marketing
Henry has been working in the
supplement industry for over 25
years. As former MD for Herbalife
Israel and Juice Plus. Henry also
has experience in the international
market with brands including NSA
Swiss, Morinda and is practiced at
developingrobust salesnetworks.
Advisory Board
Dr. Sara Kaplan
Dr. Sara Kaplan is a clinical dietitian
and leading diet expert. With over 30
years of working practice, she heads
Department of Human Nutrition and
Diet at Meuhedet, one of the Israel’s
largest private healthcare providers
and Nutritional Science at the Peres
Academic Center in Rehovot. She
holds a Ph.D in Clinical Epidemiology
from Tel-Aviv University.
Dr. Uri Eliyahu
Dr. Eliyahu has a Ph.D in Medical
Sciences specializing in
Epidemiology. As a licensed
pharmacist he holds an MSc in
Physiology and Pharmacology from
Tel Aviv University (cum laude). He is
Editor in Chief of the Israeli National
Pharmacist magazine and a leading
lecturer in many of Israel’s top
universities.
New Battleground – Consumer Healthcare
o A new consumer healthcare segment is emerging
o Healthcare products will move to the heart of the mass market
o Room to grow the brand + opportunity to exit
o Global prevalence of raised
cholesterol among adults (≥ 5.0
mmol/l) was 39% (2008).
o One third of ischaemic heart
disease is attributable to high
cholesterol.
o Estimated to cause 2.6 million
deaths (4.5% of total).
o 29.7 million (2%) of disability
adjusted life years (DALYS).
o A 10% reduction in serum
cholesterol in men aged 40 can
reduce heart disease by 50%
within 5 years.
o In high-income countries, over 50%
of adults had raised total
cholesterol.
Source: WHO estimates Global Health Observatory,
Pipeline – Large Addressable Markets
o 300 million asthma sufferers
worldwide.
o Number of asthmatics will grow by
more than 100 million by 2025.
o 250,000 annual deaths – almost all
are avoidable.
o 70% of asthmatics also have
allergies.
o World-wide, the economic costs
associated with asthma are
estimated to exceed those of TB
and HIV/AIDS combined.
Source: World Health Organization. Global
surveillance…,
o Globally, nearly one billion people
have high blood pressure
(hypertension).
o Raised blood pressure causes 7.5
million deaths (12.8% of total
deaths).
o Accounts for 57 million (3.7%)
disability adjusted life years
(DALYS).
o Blood pressure levels are shown to
be positively and continuously.
related to the risk for stroke and
coronary heart disease.
o Globally, raised blood pressure in
adults 25+ is around 40% (2008)
Source: WHO estimates Global Health Observatory,
World Heart Federation
Diabetes – the Basics
Source: http://www.idf.org/diabetesatlas/5e/the-global-burden
A Global Epidemic
Source: http://www.idf.org/diabetesatlas/5e/the-global-burden
Diabetes Market Overview
In 2013, 382 million people were diagnosed
diabetics; by 2035 this will rise to 592 million.
183 million people (50%) with diabetes are
undiagnosed
Diabetes caused 4.6 million deaths in 2011
Diabetes caused at least $458 billion in
healthcare expenditure in 2013
11% of total healthcare expenditure in
adults (20-79 years)
$
2013
2035
382M
592M
Diabetes - Impact on Healthcare
o WHO estimates one patient with diabetes dies every 6 seconds
worldwide (2013) or 5.1 million deaths.
o Global health spending to treat diabetes and manage complications
totalled at least $548 billion in 2013.
o 76% of global health expenditure on diabetes in 2013 was for
people between the ages of 50 and 79 years.
o An estimated average of $1,437 per person with diabetes was spent
globally on treating and managing the disease in 2013.
o In high income countries spend was $5,621 per person compared
with $356 in low-middle income countries.
Source: http://www.idf.org/diabetesatlas/5e/the-global-burden
CuraLin - Product Efficacy
o Within 3-5 days users can expect to see a dramatic change in blood sugar
levels. After just one month we expect to see a significant reduction as well
as an improvement in the overall health of users.
o Results showed the product was successful in improving glycemic control in
patients.
o Recognizable ingredients with evidence of blood sugar reduction properties.
Patient Impacto The application of Ayurveda practice combined with the scientific knowledge of 21st
Century medicine creates a dramatic impact on the reduction of sugar levels produced in
the body.
o The formula reactivates and strengthens the pancreas which is responsible for the
production of insulin in the body.
o Blood sugar levels reduced with attention given to the overall balance of the body.
o Clear Benefits:
o Helps lower and control blood sugar levels
o Reactivates and strengthens the pancreas
o Helps with blurred vision
o Removes any tingling sensation
o Boosts energy levels
o Reduces dependency on allopathic medication
o Completely herbal
Customer Feedback (1)
A customer survey was conducted by phone in April 2014 with data
from an uncontrolled sample group of 50 product users.
o Average age 61
o Male 66% : Female 34%
o Average length of product use 3.1 years
o 44% take no other form of diabetic treatment
% reduction after 3 months
use
% reduction till today
Users 6 - 7.9 mmol/l 8.5% 10.7%
Users 8+ mmol/l 18.6% 24.4%
Total 13.3% 17.3%
Customer Feedback (2)
How satisfied are you with the
performance of the Supplement?
I am confident in my ability to manage my
blood sugar levels?
How big an impact has it had on your
lifestyle?Would you recommend the
supplement to anyone else?
Big
Impact
84%%
Some
Impact
14%
Neutral
2%
Confident
13%
Very
Confident
84%
Neutral
3%
Yes 100%
Very
Satisfied
94%
Satisfied
6%
Thank You – Ron Elul | +972 506 724 208 | [email protected]